Insider Selling: Kewaunee Scientific Co. (NASDAQ:KEQU) CFO Sells $120,030.00 in Stock

Kewaunee Scientific Co. (NASDAQ:KEQU) CFO Donald T. Gardner III sold 3,000 shares of the firm’s stock in a transaction that occurred on Wednesday, March 26th. The stock was sold at an average price of $40.01, for a total transaction of $120,030.00. Following the completion of the transaction, the chief financial officer now directly owns 18,358 shares in the company, valued at $734,503.58. This trade represents a 14.05 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Kewaunee Scientific Trading Down 5.5 %

Shares of KEQU stock opened at $40.15 on Monday. The company has a current ratio of 2.64, a quick ratio of 2.13 and a debt-to-equity ratio of 0.45. Kewaunee Scientific Co. has a twelve month low of $30.82 and a twelve month high of $71.33. The company’s 50-day moving average price is $55.79 and its 200-day moving average price is $47.50. The stock has a market cap of $114.63 million, a price-to-earnings ratio of 6.36 and a beta of 0.71.

Kewaunee Scientific (NASDAQ:KEQU) last issued its earnings results on Wednesday, March 12th. The technology company reported $1.09 EPS for the quarter. The company had revenue of $67.17 million for the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Minerva Advisors LLC raised its position in Kewaunee Scientific by 4.1% in the fourth quarter. Minerva Advisors LLC now owns 109,493 shares of the technology company’s stock valued at $6,668,000 after purchasing an additional 4,311 shares during the period. Invesco Ltd. acquired a new stake in shares of Kewaunee Scientific during the 4th quarter worth about $6,545,000. De Lisle Partners LLP raised its holdings in Kewaunee Scientific by 36.6% in the 3rd quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock valued at $1,446,000 after buying an additional 11,511 shares during the period. American Century Companies Inc. lifted its position in Kewaunee Scientific by 18.0% in the fourth quarter. American Century Companies Inc. now owns 34,293 shares of the technology company’s stock valued at $2,122,000 after buying an additional 5,221 shares during the last quarter. Finally, O Shaughnessy Asset Management LLC boosted its stake in Kewaunee Scientific by 3.3% during the fourth quarter. O Shaughnessy Asset Management LLC now owns 28,008 shares of the technology company’s stock worth $1,733,000 after buying an additional 891 shares during the period. 32.69% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, StockNews.com cut Kewaunee Scientific from a “buy” rating to a “hold” rating in a report on Friday, March 14th.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.